(Q36322074)

13 August 2017

1 reference

title

Triclabendazole for the treatment of fascioliasis and paragonimiasis (English)

1 reference

13 August 2017

1 reference

1 reference

4

Jürg Utzinger

0 references

Jennifer Keiser

series ordinal

1

object named as

Jennifer Keiser

1 reference

13 August 2017

2

Dirk Engels

1 reference

13 August 2017

Gottfried Büscher

3

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

Expert Opinion on Investigational Drugs

13 August 2017

published in

1 reference

13 August 2017

volume

14

1 reference

13 August 2017

issue

12

1 reference

13 August 2017

page(s)

1513-1526

1 reference

Emerging foodborne trematodiasis

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

Chemotherapy for major food-borne trematodes: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

Successful treatment of human fascioliasis with nitazoxanide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

Double-blind, randomized, placebo-controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

Fasciolicides: efficacy, actions, resistance and its management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

Triclabendazole: new skills to unravel an old(ish) enigma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

Resistance of Fasciola hepatica to triclabendazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

Triclabendazole-resistant Fasciola hepatica: beta-tubulin and response to in vitro treatment with triclabendazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

Single treatment of invasive fascioliasis with triclabendazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

Effect of food on the bioavailability of triclabendazole in patients with fascioliasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

The pharmacology of flukicidal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

Triclabendazole in the treatment of Fasciola gigantica infection in swamp buffalo (Bubalus bubalis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

Randomized trial of a single, double and triple dose of 10 mg/kg of a human formulation of triclabendazole in patients with fascioliasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

Therapeutic effect of triclabendazole in patients with paragonimiasis in Cameroon: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

Treatment of human pulmonary paragonimiasis with triclabendazole: clinical tolerance and drug efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

Comparison of two single-day regimens of triclabendazole for the treatment of human pulmonary paragonimiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

Control of human fascioliasis by selective chemotherapy: design, cost and effect of the first public health, school-based intervention implemented in endemic areas of the Nile Delta, Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

A praziquantel-ineffective fascioliasis case successfully treated with triclabendazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

Fascioliasis after a stay in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

Fasciola hepatic infection in a family: diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

A new report of triclabendazole efficacy during invading phase fasciolasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

Imported Fasciola hepatica infection in the United States and treatment with triclabendazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

Human fascioliasis successfully treated with triclabendazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.12.1513

10.1517/13543784.14.12.1513

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference